Predictors of Response to Grazoprevir/Elbasvir Among HCV Genotype 1 (GT1)–Infected Patients: Integrated Analysis of Phase 2-3 Trials [Abstract 700]

Zeuzem S, Rockstroh JK, Kwo PY, et al. Predictors of Response to Grazoprevir/Elbasvir Among HCV Genotype 1 (GT1)–Infected Patients: Integrated Analysis of Phase 2-3 Trials [Abstract 700]. In 66th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), November 13-17, 2015. San Francisco, CA.; 2015.

Publication Type:

Conference Paper

Source:

66th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), November 13-17, 2015, Number 700, San Francisco, CA. (2015)
Top